Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Valproic acid clearance in children with epilepsy

A Sánchez-Alcaraz1, M B Quintana, E López

  • 1Department of Pharmacy, Arnau de Vilanova Hospital, Valencia, Spain.

Journal of Clinical Pharmacy and Therapeutics
|October 2, 1998
PubMed
Summary

Valproic acid (VPA) dosing in children with epilepsy needs age-specific adjustments. Clearance decreases with age, requiring careful pharmacokinetic monitoring for optimal VPA monotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Portable Home-Use Triglyceride Meter Demonstrates Good Agreement With Plasma Laboratory Measures During Pregnancies Complicated by Metabolic Disease.

Endocrinology, diabetes & metabolism·2026
Same author

Influence of secretome from porcine cardiosphere-derived cells on porcine macrophage polarization and their possible implications for cardiac remodeling post-myocardial infarction <i>in vitro</i>.

Frontiers in cell and developmental biology·2025
Same author

Diffuse alveolar hemorrhage as a clinical manifestation of cardiac angiosarcoma in a pregnant woman with antiphospholipid syndrome: case report and review of the literature.

Ecancermedicalscience·2025
Same author

Treatment outcomes in sinonasal aspergillosis in dogs in the United Kingdom: 436 cases (2011-2021).

The Journal of small animal practice·2025
Same author

Impact of heteroresistance on treatment outcomes of people with drug-resistant TB.

IJTLD open·2024
Same author

Diagnostic findings in sinonasal aspergillosis in dogs in the United Kingdom: 475 cases (2011-2021).

The Journal of small animal practice·2024

Area of Science:

  • Pediatric Pharmacology
  • Clinical Pharmacy
  • Epileptology

Background:

  • Valproic acid (VPA) is a widely used antiepileptic drug in children.
  • Understanding VPA pharmacokinetics in pediatric populations is crucial for effective treatment.
  • Age-related differences in drug metabolism can significantly impact VPA dosing and efficacy.

Purpose of the Study:

  • To investigate the population pharmacokinetics of VPA in children with epilepsy.
  • To establish the relationship between VPA plasma concentration and daily dose in pediatric patients.
  • To develop an age-based model for VPA dosage adjustments in monotherapy.

Main Methods:

  • Population pharmacokinetic analysis of 151 VPA plasma levels from 62 children (8 months to 6 years).

Related Experiment Videos

  • Children were on VPA monotherapy.
  • Analysis focused on steady-state VPA levels and daily doses.

    • Main Results:

    • The VPA level:dose ratio increased with age, indicating reduced clearance in older children.
    • Weight-adjusted VPA clearance (Cl) decreased significantly with increasing age.
    • A predictive equation (Cl = 47.6 x age(months)^-0.29) was derived for estimating VPA clearance based on age (8-72 months).

    Conclusions:

    • The established relationship between VPA clearance and age is vital for optimizing VPA monotherapy in children.
    • This pharmacokinetic model can guide the initial maintenance dose selection for pediatric VPA treatment.
    • Age-specific pharmacokinetic profiling enhances the safety and efficacy of VPA in pediatric epilepsy management.